Dr. Allen (Alexander) Krantz
Founder, CSO and COO
Allen Krantz has had an extensive career in academia and industry. From 1968 to 1980, he was a member of the Faculty at Stony Brook University, holding appointments in both the Department of Chemistry and Pharmacological Sciences. From 1981 to 1994, Dr. Krantz was Director, and then Vice-President of Research at Syntex Research Canada and held Adjunct Professorships during this period at the Universities of Toronto and Guelph while holding the title of Distinguished Scientist at the Corporation. From 1994 to 1997, Dr. Krantz served as Executive Vice President of Research at RedCell, Inc., the forerunner of ConjuChem, (TSX: CJC), and served as the Directeur Scientifique of the European office in France during the same period. He is also a Founder, and served as the inaugural President of Pharmena North America Incorporated, a privately held, biotechnology company. Dr. Krantz obtained his Masters of Science and Ph.D. degrees from Yale University.
Dr. Allen Krantz passed away in 2018 after a short illness. His many contributions will be remembered as the company continues to build upon his scientific legacy toward improving targeted cancer therapeutics.